Candel Therapeutics Inc (CADL)

Sep 26, 2026

Understanding Momentum Shifts in (CADL) - Stock Traders Daily

Sep 26, 2026

Sep 23, 2026

This Small-Cap Biotech Is Having Its Best Week In A Month – Here’s What’s Driving It - Stocktwits

Sep 23, 2026

Sep 22, 2026

Candel Therapeutics upgraded to Strong Buy afte... - Pluang

Sep 22, 2026

Sep 22, 2026

Candel Therapeutics: Strong Buy On Aglatimagene Prostate Cancer BLA Filing In Q4 (CADL) - Seeking Alpha

Sep 22, 2026

Sep 22, 2026

H.C. Wainwright Remains a Buy on Candel Therapeutics (CADL) - The Globe and Mail

Sep 22, 2026

Sep 21, 2026

Candel Therapeutics stock jumps on BofA upgrade to buy - Investing.com

Sep 21, 2026

Sep 21, 2026

Candel Therapeutics Shares Rise After BofA Upgrade - Yahoo Finance

Sep 21, 2026

Sep 21, 2026

H.C. Wainwright Maintains Candel Therapeutics(CADL.US) With Buy Rating, Maintains Target Price $23 - Moomoo

Sep 21, 2026

Sep 21, 2026

Candel Therapeutics stock jumps on BofA upgrade to buy By Investing.com - Investing.com South Africa

Sep 21, 2026

Sep 21, 2026

BofA upgrades Candel Therapeutics stock rating on prostate cancer progress - Investing.com

Sep 21, 2026

Sep 21, 2026

Why is Candel Therapeutics stock surging today? By Investing.com - Investing.com Canada

Sep 21, 2026

Sep 21, 2026

BofA Upgrades Candel Therapeutics to Buy From Neutral, Price Target is $18 - marketscreener.com

Sep 21, 2026

Sep 19, 2026

Why CADL Stock Plunged Nearly 15% In After-Hours Trading Today - Stocktwits

Sep 19, 2026

Sep 15, 2026

Candel Therapeutics Inc (NASDAQ:CADL) Share Price | RNS News, Quotes, & Charts | CADL | - Proactive financial news

Sep 15, 2026

Sep 15, 2026

Candel Therapeutics at H.C. Wainwright conference: prostate cancer push By Investing.com - Investing.com India

Sep 15, 2026

Sep 13, 2026

CADL Slides As Form 144 Filing Flags Insider Selling Risk - timothysykes.com

Sep 13, 2026

Sep 12, 2026

CADL Stock On Track For Best Day In Nearly 16 Months — What’s Driving The Rally? - Stocktwits

Sep 12, 2026

Sep 12, 2026

CADL Stock Edges Up After Hours On Strong Extended Prostate Cancer Data - Stocktwits

Sep 12, 2026

Sep 12, 2026

CADL Slides As Candel Therapeutics Posts Wider Q2 Loss​ - StocksToTrade

Sep 12, 2026

Sep 11, 2026

Candel Therapeutics CEO Tak sells $3.16m in CADL stock By Investing.com - Investing.com Australia

Sep 11, 2026

Sep 11, 2026

Candel Therapeutics CEO Tak sells $3.16m in CADL stock - Investing.com

Sep 11, 2026

Sep 11, 2026

Candel Therapeutics (NASDAQ: CADL) CEO sells 280K shares under preset plan - Stock Titan

Sep 11, 2026

Sep 10, 2026

Candel Therapeutics (NASDAQ: CADL) investor plans $3.4M Rule 144 stock sale from equity awards - Stock Titan

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics at Cantor global healthcare conference: prostate cancer push - Investing.com India

Sep 10, 2026

Sep 10, 2026

Candel (CADL) gives director options with 36-month vesting - Stock Titan

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics, Inc. Announces Appointment of Martine Zimmermann to Board of Directors, Effective September 8, 2026 - marketscreener.com

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics Adds Regulatory Veteran to Board Ahead of Q4 2026 BLA Submission - Minichart

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics Adds Martine Zimmermann to Board Ahead of Planned BLA Filing - citybiz

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics appoints Martine Zimmermann to board By Investing.com - Investing.com Canada

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics appoints Martine Zimmermann to board - investing.com

Sep 10, 2026

Sep 10, 2026

Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors - The Manila Times

Sep 10, 2026

Sep 10, 2026

CADL 8-K FilingsCandel Therapeutics, Inc. SEC 8-K - Stock Titan

Sep 10, 2026

Sep 10, 2026

A drug-development expert with 30 years’ experience joins Candel’s board - Stock Titan

Sep 10, 2026

Sep 09, 2026

CADL Q2 2026 Earnings: Significant EPS Shortfall as Revenue Remains AbsentFiscal Year Earnings - careplusvn.com

Sep 09, 2026

Sep 08, 2026

BB: BlackBerry Ltd Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Sep 08, 2026

Sep 06, 2026

Candel Therapeutics Reported Better-Than-Feared Q1 Loss – But All Eyes Turn To This Pivotal Event Tomorrow - Stocktwits

Sep 06, 2026

Sep 06, 2026

(CADL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Sep 06, 2026

Sep 05, 2026

Candel Therapeutics Stock Price Forecast. Should You Buy CADL? - StockInvest.us

Sep 05, 2026

Sep 02, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Sep 02, 2026

Aug 28, 2026

Show Me The Money: CADL Delivers 190%+ Gain In Less Than Six Months As BLA Filing Nears - RTTNews

Aug 28, 2026

Aug 27, 2026

Candel Therapeutics stock hits 52-week high at $13.96 By Investing.com - Investing.com South Africa

Aug 27, 2026

Aug 27, 2026

Candel Therapeutics stock hits 52-week high at $13.96 - investing.com

Aug 27, 2026

Aug 26, 2026

Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight - PR Newswire UK

Aug 26, 2026

Aug 26, 2026

Candel Therapeutics to Present at September Investor Conferences - The Manila Times

Aug 26, 2026

Aug 23, 2026

Candel (CADL) Results Versus Estimates: EPS Comes in Above Forecast for the Current Session; Stock Move: The Share Price Adds 6.32% in the Latest ReadingHealthcare Earnings Report - careplusvn.com

Aug 23, 2026

Aug 21, 2026

Candel Therapeutics (CADL) Is Up 5.4% After Steep Q2 Loss Widening Has The Bull Case Changed? - Yahoo Finance

Aug 21, 2026

Aug 21, 2026

Analysts Issue Forecasts for CADL FY2026 Earnings - MarketBeat

Aug 21, 2026

Aug 20, 2026

Candel Therapeutics, Inc. (CADL) Stock Price, News, Quote & History - Yahoo Finance

Aug 20, 2026

Aug 20, 2026

Candel Therapeutics (CADL) Faces Bigger Losses As Its Valuation Still Looks Pricey - Yahoo Finance

Aug 20, 2026